Virpax Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervo…

Biotechnology
US, Berwyn [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Virpax Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Virpax Pharmaceuticals, Inc. can't present revenue by segment

End of VRPX's Analysis
CIK: 1708331 CUSIP: 928251206 ISIN: US9282512063 LEI: - UEI: -
Secondary Listings
VRPX has no secondary listings inside our databases.